Clover Health to Report Third Quarter 2024 Financial Results on November 6
CLOV 10.23.2024

About Gravity Analytica
Recent News
- 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
- 01.13.2025 - Clover Health Reports 27% Growth in Medicare Advantage Membership, Surpassing 100,000 Lives After Strong Annual Election Period
- 01.07.2025 - Counterpart Health Deploys Counterpart Assistant with Leading Accountable Care Organization
Recent Filings
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results.
Third Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health’s Third Quarter 2024 Earnings Conference Call
- When: Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outside the U.S.) and enter the conference ID: CLOVQ324
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website athttps://investors.cloverhealth.com/for 12 months
About Clover Health:Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact onMedication Adherence, as well as the earlier identification and management ofDiabetesandChronic Kidney Disease.
Press Contact:Andrew Still-Baxterpress@cloverhealth.com
Investor Relations Contact:Ryan Schmidtinvestors@cloverhealth.com
